Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 786 of 1,261

  1. US 8865883

    Multiple exon skipping compositions for DMD

    Sarepta Therapeutics, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  2. US 8865750

    Small molecule inhibitors of RGS proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  3. US 8865751

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  4. US 8865880

    Identification of a novel BHD gene

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  5. US 8865199

    Biomatrix composition and methods of biomatrix seeding

    The Board of Regents of the University of Texas System · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  6. US 8865175

    Increasing anti-IL-1α antibodies in a subject

    XBIOTECH INC. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  7. US 8865149

    Polymeric reagents comprising a ketone or a related functional group

    Nektar Therapeutics · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  8. US 8865210

    Stable dosage formulations of imidazolylalkyl-pyridines

    VANDA PHARMACEUTICALS INC. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  9. US 8865430

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  10. US 8865230

    Compositions and methods for treating parasitic infections

    TYRATECH, INC. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  11. US 8865469

    Methods of transforming a Listeria

    The Regents of the University of California · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  12. US 8865672

    Prevention of tissue ischemia and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  13. US 8865217

    Oral preparation comprising pioglitazone

    Takeda Pharmaceutical Company Limited · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  14. US 8865748

    Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer

    Akebia Therapeutics, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  15. US 8865723

    Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury

    Tetra Discovery Partners · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  16. US 8865728

    Combinations comprising methotrexate and DHODH inhibitors

    Almirall, S.A. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  17. US 8865722

    Wet formulations of aripiprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  18. US 8865694

    Topical compositions for treatment of skin conditions

    Molecular Design International, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  19. US 8865719

    Substituted heterocycles and their use as allosteric modulators of nicotinic and GABAA receptors

    The Regents of the University of California · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  20. US 8859727

    Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

    The Board of Regents of the University of Texas System · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  21. US 8859774

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  22. US 8859750

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  23. US 8859736

    Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  24. US 8858938

    Human monoclonal antibodies against Hendra and Nipah viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.